Lantern Pharma Inc. (LTRN) Discusses Live Demonstration of withZeta.ai Platform for AI-Driven Oncology Drug Discovery Transcript
Lantern Pharma Inc. held a live demonstration of its withZeta.ai platform, an AI-driven system designed to accelerate oncology drug discovery, particularly for rare cancers. The event showcased the platform's ability to process complex scientific data and generate real-time research insights. CEO Panna Sharma and RedChip Companies' Paul Kuntz participated in the presentation, emphasizing the transformative potential of AI in drug development.
- ▪Lantern Pharma Inc. conducted a live demonstration of its withZeta.ai AI platform on April 30, 2026.
- ▪The withZeta.ai platform is focused on advancing oncology drug discovery, especially for rare cancers.
- ▪The demonstration showed real-time execution of research workflows and synthesis of scientific data.
- ▪Panna Sharma, President and CEO of Lantern Pharma, participated in the event.
- ▪Paul Kuntz of RedChip Companies hosted the session and highlighted the platform's innovative capabilities.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4896976-lantern-pharma-inc-ltrn-discusses-live-demonstration-of-withzeta-ai-platform-for-ai-driven"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
